DS-121

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameDS-121
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, MajorSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A